F P LaCreta

Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer.

Peter J. O’Dwyer, Thomas C. Hamilton, F P LaCreta et al. · Journal of Clinical Oncology · 1996 · 160 citations

Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid.

Peter J. O’Dwyer, F P LaCreta, Sherry Nash et al. · PubMed · 1991 · 147 citations

Ethacrynic Acid, Chemoprevention Strategy, Pathology +17

Phase I/pharmacokinetic study of topotecan by 24-hour continuous infusion weekly.

Naomi B. Haas, F P LaCreta, Judy Walczak et al. · PubMed · 1994 · 85 citations

Pharmaceutical Science, 24-Hour Continuous Infusion, Oncology +15

Phase I/pharmacokinetic reevaluation of thioTEPA.

Peter J. O’Dwyer, F P LaCreta, P Engstrom et al. · PubMed · 1991 · 50 citations

Phase I/pharmacokinetic Reevaluation, Pharmacotherapy, Immunotherapy +16

Phase I trial of thiotepa in combination with recombinant human granulocyte-macrophage colony-stimulating factor.

Peter J. O’Dwyer, F P LaCreta, Russell J. Schilder et al. · Journal of Clinical Oncology · 1992 · 29 citations